Outcome
    Strong Evidence

    Saffron for Mood & Mental Health Support

    Saffron has the strongest herbal antidepressant evidence, matching fluoxetine and imipramine in multiple head-to-head RCTs for mild-to-moderate depression.

    Overview

    Saffron has the strongest herbal antidepressant evidence, matching fluoxetine and imipramine in multiple head-to-head RCTs for mild-to-moderate depression.

    How It Works

    Crocin and safranal inhibit serotonin, dopamine, and norepinephrine reuptake, with additional NMDA antagonism and anti-inflammatory effects on neuroinflammatory pathways implicated in depression.

    Dosing & Protocol

    Typical dose

    Recommended dose
    30 mg/day standardized extract (15 mg twice daily) for at least 6–8 weeks.
    Expected timeframe
    6-8 weeks

    Protocol

    form
    Standardised Crocus sativus stigma extract, typically 2% safranal or 3.5% crocin; affron and Satiereal extracts were used in trials. Saffron is expensive and adulteration with safflower, turmeric or dyed material is common, so third-party testing matters
    duration
    6-8 weeks
    co factor
    Take with food to reduce nausea. Evidence is comparatively strong for a botanical. Multiple randomised placebo-controlled trials and several meta-analyses find saffron at 30 mg/day reduces depressive and anxiety symptoms in mild to moderate presentations with a moderate to large effect size, and head-to-head trials against fluoxetine 20-40 mg/day and imipramine found broadly comparable symptom reduction over 6-8 weeks. The caveats are real: trials are small, short, overwhelmingly conducted in Iran, several have industry links, and effect sizes shrink in more rigorous analyses. Severe depression has not been studied.
    titration
    30 mg/day is the dose used in nearly all positive trials; higher doses add risk without demonstrated benefit
    starting dose
    15 mg twice daily with breakfast and the evening meal

    Evidence

    What the studies say

    Meta-analyses of RCTs consistently find saffron significantly superior to placebo and non-inferior to fluoxetine (20 mg) and imipramine for mild-moderate depression, with fewer side effects. Trials are mostly Iranian and modest in size — the main limitation on the evidence.

    The effects of an oral saffron extract on psychological well-being in healthy adults with low mood: a randomised, double-blind, placebo-controlled study

    Score: 6/10
    2017
    rct
    n=128

    Kell G, Rao A, Beccaria G +3 more

    A standardised saffron extract improved mood and reduced stress and anxiety scores in healthy adults with low mood over four weeks.

    View source

    Effects of Saffron Extract Supplementation on Mood, Well-Being, and Response to a Psychosocial Stressor in Healthy Adults: A Randomized, Double-Blind, Parallel Group, Clinical Trial

    Score: 7/10
    2021
    rct
    n=56

    Jackson PA, Forster J, Khan J +14 more

    Saffron extract produced no significant change on most primary mood measures in healthy adults.

    View source

    Safety

    Caveats

    Doses above 1.5 g/day are toxic (stick to standardized extracts); avoid in pregnancy; possible additive effect with serotonergic drugs — coordinate with a prescriber.

    Less likely to help if

    Severe or treatment-resistant depression requires clinical care; saffron trials excluded these populations.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.